The use of individualized tumor response testing in treatment selection: Second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry

Ähnliche Einträge

• The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.
  von: Matutes, E, et al.
  Veröffentlicht: (2013)
• Quality of life in the LRF CLL4 trial.
  von: Else, M, et al.
  Veröffentlicht: (2005)
• Prognostic factors in the UK LRF CLL4 trial
  von: Oscier, D, et al.
  Veröffentlicht: (2006)
• The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.
  von: Catovsky, D, et al.
  Veröffentlicht: (2006)
• Quality of life in the UK LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)
  von: Else, M, et al.
  Veröffentlicht: (2006)